Description: Elevance Health stock has seen its fair value estimate rise slightly from $386.11 to $387.16, based on updated analyst expectations. This minor increase reflects analysts’ evolving perspectives in light of ongoing regulatory changes and shifting industry headwinds. Read on to discover how you can keep up with the latest developments shaping the narrative around Elevance Health’s outlook. Analyst Price Targets don't always capture the full story. Head over to our Company Report to find new...

Description: Curious if Elevance Health is now a bargain or still too pricey? You are not alone. Many investors are searching for clues about the company’s true value and long-term potential. Despite a challenging year, Elevance Health’s stock recently gained 5.1% in the past week and is up 0.6% over the past month. However, it remains down 7.5% year-to-date and 15.4% over the last 12 months. Shares have moved as the healthcare sector faces shifting regulations and market updates. Investor sentiment has...

Description: Teladoc (TDOC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Description: UnitedHealth grapples with a surging MCR as Optum's strength steadies results while Washington's policy moves loom large.

Description: Check out the companies making headlines this week:

Description: Reports emerged recently that the White House is preparing to extend Affordable Care Act premium subsidies for two years, with new eligibility limits also under consideration. This policy change could have a direct effect on health insurers like Elevance Health by making coverage more affordable and potentially expanding their customer base. We'll examine how the possible extension of ACA subsidies shapes Elevance Health's investment narrative, especially as it relates to future membership...

Description: For many investors, the main point of stock picking is to generate higher returns than the overall market. But in any...

Description: UnitedHealth pushes its hybrid care model forward, merging digital tools with in-person care as it extends this approach across global markets.

Description: Check out the companies making headlines yesterday:

Description: Shares of health insurance provider Elevance Health (NYSE:EVH) jumped 2.1% in the afternoon session after reports indicated the White House was preparing to unveil a health policy framework that would extend Affordable Care Act (ACA) premium subsidies for two years.

Description: Major U.S. equities indexes climbed Monday afternoon as tech stocks rallied, and as optimism about a rate cut by the Federal Reserve next month grew.

Description: INDIANAPOLIS, November 24, 2025--Elevance Health is making healthcare more intuitive and personalized by using technology to simplify access and build trust among health plan members.

Description: Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are usually cheap for a reason – five cents for a piece of fruit may seem like a great deal until you find out it’s rotten.

Description: Shares of Elevance Health (ELV) have recently moved, sparking conversations about what is driving sentiment and where the stock stands now. With swings in the past month and muted returns over the year, investors are taking a closer look at the numbers. See our latest analysis for Elevance Health. After climbing sharply in a single session, Elevance Health’s share price remains in negative territory for the year, with a 12.05% year-to-date drop and a one-year total shareholder return of...

Description: TDOC's steady stream of acquisitions is expanding its global reach and lifting growth across key segments in 2025.

Description: Elevance Health (ELV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Description: Although Elevance Health has underperformed the broader market over the past year, Wall Street maintains a generally upbeat view on its prospects.

Description: Insights from Glenn Greenberg (Trades, Portfolio)'s Third Quarter 2025 13F Filing

Description: Wondering whether Elevance Health is trading at bargain levels or priced for perfection? You're not alone; getting a handle on valuation can help you spot opportunity or avoid hidden pitfalls. The stock has been on a bit of a rollercoaster lately, with a 4.4% gain over the past week but still down 10.3% year-to-date and off 17.9% for the last year. Analysts are keeping a close eye on Elevance Health as sector-wide healthcare reform discussions and evolving regulations continue to dominate...

Description: UnitedHealth shares dipped earlier this week as Trump’s populist healthcare remarks rattled insurers, but fundamentals and long-term guidance may tell a more resilient story.

Description: A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid growing valuation concerns.

Description: Madison Investments, an investment advisor, released its “Madison Large Cap Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund decreased 2.2% in the third quarter compared to an 8.1% gain for the S&P 500 Index. The current market focus on short-term profits led the fund to underperform the […]

Description: CVS raises its full-year EPS outlook after a strong quarter, driven by gains across all segments and solid pharmacy growth.

Description: Elevance Health recently reaffirmed its 2025 earnings guidance and projected a benefit expense ratio of about 90.0% during presentations to investors and at healthcare industry conferences in early November 2025. This ongoing transparency and emphasis on operational stability comes as the company addresses industry headwinds, including margin pressures and increased competition in government-sponsored programs. We'll examine how Elevance Health's confident reiteration of its earnings outlook...

Description: <body><p>STORY: Shares of health insurers tumbled Monday after the U.S. Senate struck a deal to end the government shutdown without extending Affordable Care Act subsidies.</p><p>Shares of Centene slid as much as 10.5%, while Molina Healthcare slipped more than 7.5%, and Elevance Health shed as much as 5%.</p><p>Disagreement over extending the subsidies, which are due to expire at the end of the year, has been at the heart of the record-long shutdown.</p><p>Without them, most of the 24 million people enrolled in these plans will see a sharp increase in their health insurance costs for 2026.</p><p>But Republicans and a small group of Democrats agreed to a December vote on potentially extending the subsidies, which have been in place since 2021.</p><p>The subsidies have allowed enrollment in the Affordable Care Act, otherwise known as Obamacare, to double in size.</p><p>Meanwhile, President Donald Trump on Sunday reiterated a call to end the subsidies, posting on social media that they were a "windfall for Health Insurance Companies, and a DISASTER for the American people," a comment that one analyst said could infuse more uncertainty for insurers.</p></body>

Description: Centene, the largest health insurer based on Affordable Care Act Marketplace enrollment and hospital operator HCA Healthcare were the worst-performing S&P 500 stocks early Monday after a weekend deal toward ending the government shutdown left the fate of expiring ACA subsidies unsettled. Meanwhile, the overall S&P 500 rallied strongly on expectations that the government reopening will give the economy a needed shot in the arm. The seven Democrats and one independent who joined 52 Republicans to advance a reopening bill could only extract a commitment to hold a vote on renewing the enhanced ACA subsidies.

Description: President Donald Trump wrote that "hundreds of billions" in federal funding should be shifted from "money sucking" health insurers to the public.

Description: Pelican Bay Capital Management, an investment management company, released its third-quarter 2025 investor letter. A copy of the same can be downloaded here. PBCM Concentrated Value Strategy returned 7.8% in the quarter, compared to a 5.3% return for the Russell 1000 Value Index. YTD, the fund returned 11.2% compared to 11.6% for the index. In addition, […]

Description: President Donald Trump wrote that "hundreds of billions" in federal funding should be shifted from "money sucking" health insurers to the public.

Description: The fact that multiple Elevance Health, Inc. ( NYSE:ELV ) insiders offloaded a considerable amount of shares over the...

Description: HUM tops Q3 earnings forecasts on strong premium growth, even as higher costs and lower memberships weigh on results.

Description: Most readers would already be aware that Elevance Health's (NYSE:ELV) stock increased significantly by 13% over the...

Description: Elevance Health (ELV) has seen some movement in its share price lately, prompting investors to take a closer look at recent performance trends. Over the past 3 months, the stock is up around 17%. See our latest analysis for Elevance Health. Elevance Health has experienced some volatility, but the share price rally of 17% over the past quarter stands out given the backdrop of a 12% year-to-date decline and a 1-year total shareholder return loss of 19%. Recent moves suggest momentum could be...

Description: CI's Q3 results hinge on strong Evernorth growth and surging investment income, but lower premiums and rising costs may weigh on margins.

Description: Investors need to pay close attention to ELV stock based on the movements in the options market lately.

Description: Shares of the embattled health insurer Centene jumped almost 8% on Wednesday after medical costs for its Medicaid plans came in below expectations, leaving it with better-than-expected third quarter results. Shares plummeted 40% in a single day in early July when the company withdrew its 2025 financial guidance, citing worries about the plans it offers on the Affordable Care Act exchanges. Since then, the stock has been “bouncing near the bottom like a pogo stick in an infinity pool,” as Mizuho healthcare equity strategist Jared Holz put it in an email to investors early Wednesday.

Description: UHS posts a 53% YoY EPS surge in Q3 on higher admissions and improved patient days. Management hikes its 2025 EPS forecast to $21.50-$22.10.

Description: UnitedHealth Group stock rose Tuesday after a slightly better-than-expected quarter for the company’s health insurance division led to a modest earnings beat. The stock jumped more than 4% in the premarket hours, a surprisingly big jump given the results, which were largely in line with expectations. It was an indication of Wall Street’s eagerness to see signs of recovery in the stock, which suffered a historic selloff this spring.

Description: DURHAM, N.C., October 28, 2025--Sightview, the only electronic health record and practice management partner focused solely on eyecare, has appointed D. Scott Foster (Scott), CPA, MBA, as chief financial officer. With more than thirty years of experience in healthcare finance, Scott joins Sightview as the organization continues to reshape itself for the future of eyecare.

Description: Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...

Description: ​Elevance Health, Inc. (NYSE:ELV) is one of the Most Undervalued Long Term Stocks to Buy Right Now. On October 21, Sarah James from Cantor Fitzgerald reiterated a Buy rating on Elevance Health, Inc. (NYSE:ELV) with a price target of $400. ​The firm maintains a cautious outlook on the 2026 Medicaid Environment, noting that the company […]

Description: Third quarter earnings season is ramping up, and analysts expect S&P 500 companies grew their profits by 8% during the quarter.

Description: Molina Healthcare stock fell by more than 20% on Thursday after the company posted a miss on earnings per share and slashed its guidance for the fourth quarter.

Description: Elevance Health, Inc. (NYSE:ELV) is one of the best long term low volatility stocks to buy right now. Elevance Health, Inc. (NYSE:ELV) reported its fiscal Q3 2025 results on October 21, announcing $50.1 billion in operating revenue for the quarter, up 12.0% compared to the same quarter last year. Diluted EPS for the quarter reached […]

Description: Third quarter earnings season is ramping up, and analysts expect S&P 500 companies grew their profits by 8% during the quarter.

Description: MINNEAPOLIS, October 22, 2025--HistoSonics Expands Insurance Coverage for Non-Invasive Liver Tumor Treatment to 45.4 Million Elevance Health Members

Description: Elevance Health (ELV) is expected to grow earnings by 10.78% per year, with annual revenue growth forecast at 5.2%. While net profit margins have narrowed to 2.8% from 3.7% last year, the company has delivered 3.8% annual earnings growth over the past five years and maintains a reputation for high-quality earnings. Investors are eyeing these results for signs of ongoing profit and revenue growth, appealing valuation, and dividend potential, particularly with steady, if unspectacular, profit...

Description: Third quarter earnings season is ramping up, and analysts expect S&P 500 companies grew their profits by 8% during the quarter.

Description: Elevance Health Inc (ELV) reports robust revenue growth and strategic investments in AI, while navigating Medicaid margin pressures and ACA market uncertainties.

Description: ELV beats EPS estimates by 21% in Q3 as strong Medicare Advantage membership gains and Carelon revenue growth offset Medicaid losses.

Description: Shares of health insurance provider Elevance Health (NYSE:EVH) fell 3.2% in the morning session after the company reported third-quarter results showing that rising medical costs squeezed profits, despite an increase in revenue.

Description: The health insurer’s results looked strong at first glance, but the stock fell as management discussed margins in its Medicaid business.

Description: The headline numbers for Elevance Health (ELV) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Description: Elevance Health logged higher profit in the third quarter as revenue rose, despite a slip in overall memberships.

Description: US equity futures were pointing lower on Tuesday as investors assess the critical minerals deal betw

Description: Elevance Health (ELV) delivered earnings and revenue surprises of +21.08% and +1.15%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Description: Investing.com -- Elevance Health Inc. (NYSE: ELV) reported third-quarter earnings that significantly exceeded analyst expectations, sending shares up 4.1% premarket as investors responded positively to the healthcare giant’s performance.

Description: Health insurance provider Elevance Health (NYSE:EVH) announced better-than-expected revenue in Q3 CY2025, with sales up 12.4% year on year to $50.71 billion. Its non-GAAP profit of $6.03 per share was 22% above analysts’ consensus estimates.

Description: On a per-share basis, the Indianapolis-based company said it had profit of $5.32. Earnings, adjusted for one-time gains and costs, were $6.03 per share. The results surpassed Wall Street expectations.

Description: INDIANAPOLIS, October 21, 2025--Elevance Health, Inc. (NYSE: ELV) reported third quarter 2025 results.

Description: The Indianapolis-based company is the first major insurer to release earnings this cycle. Elevance did well in the quarter, but hinted that profits could be constrained in 2026.

Description: The Shareholders Foundation, Inc. recently reported an update to the ongoing lawsuit for certain Elevance Health investors, highlighting amended allegations that the company misrepresented its monitoring and rate-setting practices around Medicaid redeterminations, which may have understated cost and risk impacts in previous guidance. This development comes just as Elevance Health prepares to release its third-quarter earnings, with analysts anticipating strong revenue growth but a...

Description: Third quarter earnings season is ramping up, and analysts expect S&P 500 companies grew their profits by 8% during the quarter.

Description: As investors enters shutdown week three, a US-China trade war, credit gesticulation, and an incoming oil glut are weighing on the market.